TScan Therapeutics awards retention grants to CEO, CLO
TScan Therapeutics approved a retention program granting cash and RSUs to CEO Gavin MacBeath and Chief Legal and Strategy Officer Zoran Zdraveski.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.